EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient‐Derived Neurons Exhibit α‐Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein–Associated Neurodegeneration

Leonie M Heger, Leonie Kertess, Clara Kaufhold, Francesco Gubinelli, Aida Cardona-Alberich, Gamze Özata, Stephan A Müller iD, Sarah K Tschirner, Oliver Stehling, Martina Schifferer, Camille Peron, Valeria Tiranti und 7 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.70029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Leonie M Heger und 18 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: alpha-Synuclein, Dopaminergic Neurons, Neuroaxonal Dystrophies, Histocompatibility Antigens Class I. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission 7th Framework Programme, project TIRCON, Linea Azione 4.1; T4-AN-09 of the Italian Ministry of health, project POS, Pezzoli Foundation for Parkinson's Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitochondrial membrane protein–associated neurodegeneration (MPAN) from the neurodegeneration with brain iron accumulation (NBIA) family is a rare neurodegenerative disease marked by α‐synuclein aggregation, brain iron accumulation, and midbrain dopaminergic neuron degeneration.

Objective

The mechanisms driving neuron vulnerability remain unclear. Our study aimed to develop a patient‐derived disease model replicating key pathologies of patient brains.

Methods

We generated induced pluripotent stem cell–derived midbrain dopaminergic neurons from MPAN patients and examined ultrastructural and biochemical markers of pathology.

Results

MPAN patient neurons displayed α‐synuclein aggregation, axonal swellings, iron accumulation, and severe membrane destruction. In addition, levels of the major histocompatibility complex class I (MHC‐I), linked to cellular stress and neurodegenerative processes, were elevated in patient neurons. Treatment with acetyl‐leucine, a potentially neuroprotective compound, decreased MHC‐I.

Conclusions

This first patient‐derived neuronal model of MPAN provides a useful tool for further research aimed at unraveling the complexities of this disease and developing potential therapeutic interventions. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinDopaminergic NeuronsNeuroaxonal DystrophiesHistocompatibility Antigens Class IIron Metabolism DisordersNeurodegenerative DiseasesHumansInduced Pluripotent Stem CellsMaleFemaleMiddle AgedMesencephalonAgedNeurons

Stichwörter der Autor:innen

MPANNBIAdopaminergic neuronsiPSC disease modelingα‐synuclein

Substanzen

alpha-SynucleinHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany.
  • Neuroproteomics, School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Institute for Cytobiology, Philipps University of Marburg, Marburg, Germany.
  • Centre for Synthetic Microbiology, Synmikro, Marburg, Germany.
  • Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

ORCID-Profile: Stephan A Müller, Wolfgang Oertel, Lena F Burbulla

Förderung

  • European Commission 7th Framework Programme, project TIRCON
  • Linea Azione 4.1; T4-AN-09 of the Italian Ministry of health, project POS
  • Pezzoli Foundation for Parkinson's Disease
  • Deutsche Forschungsgemeinschaft
  • Germany's Excellence Strategy within the framework of the Munich Cluster of Systems Neurology
  • Federal Ministry for Education and Research (BMBF)
  • Mariani Foundation
  • NBIA Disorders Association (NBIADA, USA), Associazione Italiana Sindromi Neurodegenerative da Accumulo di Ferro (AISNAF, Italy), Hoffnungsbaum e.V. (HoBa, Germ…

Zitieren

APA

Heger, L. M., Kertess, L., Kaufhold, C., Gubinelli, F., Cardona-Alberich, A., Özata, G., Müller, S. A., Tschirner, S. K., Stehling, O., Schifferer, M., Peron, C., Tiranti, V., Lill, R., Iuso, A., Zecca, L., Strupp, M., Oertel, W., Lichtenthaler, S. F., & Burbulla, L. F. (2025). Patient‐Derived Neurons Exhibit α‐Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein–Associated Neurodegeneration. Movement Disorders. https://doi.org/10.1002/mds.70029

Vancouver

Heger LM, Kertess L, Kaufhold C, Gubinelli F, Cardona-Alberich A, Özata G, et al. Patient‐Derived Neurons Exhibit α‐Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein–Associated Neurodegeneration. Movement Disorders. 2025. doi:10.1002/mds.70029

BibTeX
@article{Heger2025,
  author = {Heger, Leonie M and Kertess, Leonie and Kaufhold, Clara and Gubinelli, Francesco and Cardona-Alberich, Aida and Özata, Gamze and Müller, Stephan A and Tschirner, Sarah K and Stehling, Oliver and Schifferer, Martina and Peron, Camille and Tiranti, Valeria and Lill, Roland and Iuso, Arcangela and Zecca, Luigi and Strupp, Michael and Oertel, Wolfgang and Lichtenthaler, Stefan F and Burbulla, Lena F},
  title = {Patient‐Derived Neurons Exhibit α‐Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein–Associated Neurodegeneration},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.70029}
}
Kostenlos starten →